Article thumbnail
Location of Repository

Suppression of RhoG activity is mediated by a syndecan 4–synectin–RhoGDI1 complex and is reversed by PKCα in a Rac1 activation pathway

By Arye Elfenbein, John M. Rhodes, Julia Meller, Martin A. Schwartz, Michiyuki Matsuda and Michael Simons

Abstract

Fibroblast growth factor 2 (FGF2) is a major regulator of developmental, pathological, and therapeutic angiogenesis. Its activity is partially mediated by binding to syndecan 4 (S4), a proteoglycan receptor. Angiogenesis requires polarized activation of the small guanosine triphosphatase Rac1, which involves localized dissociation from RhoGDI1 and association with the plasma membrane. Previous work has shown that genetic deletion of S4 or its adapter, synectin, leads to depolarized Rac activation, decreased endothelial migration, and other physiological defects. In this study, we show that Rac1 activation downstream of S4 is mediated by the RhoG activation pathway. RhoG is maintained in an inactive state by RhoGDI1, which is found in a ternary complex with synectin and S4. Binding of S4 to synectin increases the latter's binding to RhoGDI1, which in turn enhances RhoGDI1's affinity for RhoG. S4 clustering activates PKCα, which phosphorylates RhoGDI1 at Ser96. This phosphorylation triggers release of RhoG, leading to polarized activation of Rac1. Thus, FGF2-induced Rac1 activation depends on the suppression of RhoG by a previously uncharacterized ternary S4–synectin–RhoGDI1 protein complex and activation via PKCα

Topics: Research Articles
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2712988
Provided by: PubMed Central

Suggested articles

Citations

  1. (2000). Ezrin links syndecan-2 to the cytoskeleton.
  2. (2002). Fibroblast growth factor–specific modulation of cellular response by syndecan-4.
  3. (2005). Local phosphatidylinositol 3,4,5-trisphosphate accumulation recruits
  4. (1996). Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway.
  5. (2007). RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs.
  6. (2002). RhoGDI-3 regulates RhoG and targets this protein to the Golgi complex through its unique N-terminal domain.
  7. (2005). RhoGDI: multiple functions in the regulation of Rho family GTPase activities.
  8. (2006). Selective regulation of arterial branching morphogenesis by synectin.
  9. (2004). SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis.
  10. (2007). Syndecan-4–dependent Rac1 regulation determines directional migration in response to the extracellular matrix.
  11. (2007). Syndecans in wound healing, inflammation and vascular biology.
  12. (2000). Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.